These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 920042)

  • 21. Effect of ergonovine on prolactin secretion and milk let-down.
    Canales ES; Garrido JT; Zárate A; Mason M; Soria J
    Obstet Gynecol; 1976 Aug; 48(2):228-9. PubMed ID: 940657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lactogenesis induced by prostaglandin F2 alpha in pregnant rabbits.
    Deis RP; Houdebine LM; Delouis C
    Adv Prostaglandin Thromboxane Res; 1980; 8():1317-20. PubMed ID: 7376985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone release and abortifacient effectiveness of a newly developed silastic device containing 15-ME-PGF2alpha methyl ester in concentrations of 0.5% and 1.0%.
    Lauersen NH; Wilson KH
    Prostaglandins; 1976; 12 Suppl():63-79. PubMed ID: 968066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of two types of prostaglandins for abortion during the second trimester.
    Rettenmaier MA; Hanson FW
    Surg Gynecol Obstet; 1983 May; 156(5):585-8. PubMed ID: 6573807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The combined oral contraceptive pill versus bromocriptine to suppress lactation in puerperium: a randomized double blind study.
    Piya-Anant M; Worapitaksanond S; Sittichai K; Saechua P; Nomrak A
    J Med Assoc Thai; 2004 Jun; 87(6):670-3. PubMed ID: 15279347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of lactation by a long-acting bromocriptine.
    Peters F; Del Pozo E; Conti A; Breckwoldt M
    Obstet Gynecol; 1986 Jan; 67(1):82-5. PubMed ID: 3940343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prostaglandin F2alpha (PGF2alpha) and prolactin secretion under various experimental conditions].
    Murri S; Melis GB; Fruzzeti F; Paoletti AM; Tallarico N; Fioretti P
    Minerva Ginecol; 1981 Jun; 33(6):528-31. PubMed ID: 7197005
    [No Abstract]   [Full Text] [Related]  

  • 28. Bromocriptine mesylate for prevention of postpartum lactation.
    Duchesne C; Leke R
    Obstet Gynecol; 1981 Apr; 57(4):464-7. PubMed ID: 7243095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of enzaprost F on the dilatation of cervical canal following intracervical and extra-ovular application in the first trimester of pregnancy.
    Pajor A; Matányi S; Lintner F; Soltész K; Siklós P; Hintalan A
    Ther Hung; 1985; 33(4):193-7. PubMed ID: 3870230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of lactation. A comparison of bromocriptine and prostaglandin E2.
    England MJ; Tjallinks A; Hofmeyr J; Harber J
    J Reprod Med; 1988 Jul; 33(7):630-2. PubMed ID: 3172062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of routine administration of methylergometrin during puerperium on involution, maternal morbidity and lactation].
    Arabin B; Rüttgers H; Kubli F
    Geburtshilfe Frauenheilkd; 1986 Apr; 46(4):215-20. PubMed ID: 3519353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of furosemide on serum prolactin levels in the postpartum period.
    Kalk WJ; Cominos DC; van der Walt A; van Rooyen AJ
    S Afr Med J; 1977 Sep; 52(12):485-6. PubMed ID: 905911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of lactation comparing stilboestrol and bromocriptine (CB154).
    Ladipo OA; Ojo OA
    Niger Med J; 1979 Jan; 9(1):77-9. PubMed ID: 463344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical evaluation of the effectiveness of prostaglandin F 2-alpha in suppression of lactation in the puerperium. Experience in 50 cases].
    Caminiti F; Nasi A; De Murtas M; Parodo G; Mascia P; Fioretti P
    Minerva Ginecol; 1979 Dec; 31(12):879-83. PubMed ID: 575857
    [No Abstract]   [Full Text] [Related]  

  • 35. Metergoline in the inhibition of puerperal lactation.
    Delitala G; Masala A; Alagna S; Devilla L; Lotti G
    Br Med J; 1977 Mar; 1(6063):744-6. PubMed ID: 322792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of puerperal lactation: evaluation of bromocriptine and placebo.
    Bhardwaj N
    Aust N Z J Obstet Gynaecol; 1979 Aug; 19(3):154-7. PubMed ID: 391210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of dihydroergocryptine on serum prolactin levels and milk secretion in puerperal women.
    Nappi C; Colace G; Di Carlo C; Affinito P; Ruotolo C; Montemagno R; Farace MJ; Mailland F; Di Renzo GF
    Gynecol Endocrinol; 1993 Jun; 7(2):129-33. PubMed ID: 8213227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of lactation and inhibition of prolactin release after mechanical breast stimulation in puerperal women given tamoxifen or placebo.
    Masala A; Delitala G; Lo Dico G; Stoppelli I; Alagna S; Devilla L
    Br J Obstet Gynaecol; 1978 Feb; 85(2):134-7. PubMed ID: 626722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies on the modification of puerperal lactation using methylergobrevin].
    Plesse R; Tomski A
    Zentralbl Gynakol; 1977; 99(25):1558-63. PubMed ID: 610238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Piribedil inhibition of prolactin release induced by mechanical breast emptying in puerperal women.
    Alagna S; Lodico G; Devilla L; Masala A; Delitala G; Rovasio PP; Stoppelli I
    Clin Endocrinol (Oxf); 1979 Sep; 11(3):301-5. PubMed ID: 389484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.